Inverse association of p16 INK4a and p14 ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer (Q44285666)

1 December 2017

title

Inverse association of p16 INK4a and p14 ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer (English)

1 reference

1 December 2017

B Verdoodt

1

1 reference

1 December 2017

F Sommerer

2

1 reference

1 December 2017

R-J Palisaar

3

1 reference

1 December 2017

J Noldus

4

1 reference

1 December 2017

M Vogt

5

1 reference

1 December 2017

S Nambiar

6

1 reference

1 December 2017

A Tannapfel

7

1 reference

1 December 2017

A Mirmohammadsadegh

8

1 reference

1 December 2017

M Neid

9

1 reference

1 December 2017

publication date

13 September 2011

1 reference

Prostate Cancer and Prostatic Diseases

1 December 2017

published in

1 reference

1 December 2017

volume

14

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

295-301

1 reference

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Gleason grading and prognostic factors in carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

An update of the Gleason grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Molecular markers of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Genomic profiling of tumor initiating prostatospheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Advances in proteomic prostate cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Epigenetic changes in prostate cancer: implication for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

DNA methylation changes in prostate cancer: current developments and future clinical implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Beyond prostate-specific antigen: alternate serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

A quantitative promoter methylation profile of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Methylation-based biomarkers for early detection of urological cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Intratumoral expression of respiratory syncytial virus fusion protein in combination with cytokines encoded by adenoviral vectors as in situ tumor vaccine for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

PTEN inhibits BMI1 function independently of its phosphatase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Polycomb CBX7 has a unifying role in cellular lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Epigenetic stem cell signature in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Global histone modification patterns predict risk of prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

A polycomb repression signature in metastatic prostate cancer predicts cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

"Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Stem cell origin of death-from-cancer phenotypes of human prostate and breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Frequent p16-independent inactivation of p14ARF in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

The regulation of INK4/ARF in cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

DNA methylation of HOXD3 as a marker of prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2011.45

31 March 2020

Identifiers

DOI

10.1038/PCAN.2011.45

1 reference

1 December 2017

1 reference